| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 4024520 | Journal Français d'Ophtalmologie | 2010 | 7 Pages |
Abstract
In this small series of eyes with limited follow-up, intravitreal ranibizumab was a safe and effective treatment for CNV secondary to pathological myopia, resulting in functional and anatomic improvements.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Ophthalmology
Authors
P.-L. Cornut, M. Poli, A. Feldman, H. El Chehab, B. Swalduz, C. Burillon, P. Denis,